Open · PA-27-100 · CFDA 93.068;93.070;93.073;93.083;93.084;93.103;93.113;93.121;93.136;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.313;93.326;93.350;93.351;93.361;93.393;93.394;93.395;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879 · Discretionary

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

Varies
Award range
Open
Status
235d
Days left
-
Expected awards

The verdict

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) is an open discretionary opportunity from National Institutes of Health, offering Varies by applicant. Applications close in 235 days.

Varies
award range
Open
235 days left
93.068;93.070;93.073;93.083;93.084;93.103;93.113;93.121;93.136;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.313;93.326;93.350;93.351;93.361;93.393;93.394;93.395;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879
CFDA program

Opportunity snapshot. This Grants.gov announcement - NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) - is cataloged under number PA-27-100 and tied to CFDA assistance listing 93.068;93.070;93.073;93.083;93.084;93.103;93.113;93.121;93.136;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.313;93.326;93.350;93.351;93.361;93.393;93.394;93.395;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on May 28, 2026 and last updated on June 1, 2026. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. Applications close on April 5, 2027 - roughly 235 days from today. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

Varies by applicant

Close Date

April 5, 2027

Posted

May 28, 2026

Instrument

Grant

Description

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Eligibility

Grants.gov lists this opportunity under eligibility category code 23. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH SEED (Small business Education and Entrepreneurial Development) SEEDinfo@nih.gov

Key Dates

Posted May 28, 2026
Close Date April 5, 2027
Archive Date June 4, 2027
Last Updated June 1, 2026

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)", offered by National Institutes of Health. It is associated with CFDA program 93.068;93.070;93.073;93.083;93.084;93.103;93.113;93.121;93.136;93.142;93.143;93.172;93.173;93.213;93.233;93.242;93.273;93.279;93.286;93.307;93.313;93.326;93.350;93.351;93.361;93.393;93.394;93.395;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.859;93.865;93.866;93.867;93.879. The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies ...
Is this opportunity still open?
Yes, this opportunity is currently open for applications. The closing date is April 5, 2027.
How much funding is available?
The award range for this opportunity is Varies by applicant.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants